An official website of the United States government.

The .gov means it’s official.
Federal government websites always use a .gov or .mil domain. Before sharing sensitive information online, make sure you’re on a .gov or .mil site by inspecting your browser’s address (or “location”) bar.

This site is also protected by an SSL (Secure Sockets Layer) certificate that’s been signed by the U.S. government. The https:// means all transmitted data is encrypted — in other words, any information or browsing history that you provide is transmitted securely.

A new Genetic Approach for Studying Prions and Other Pathogenic Protein Aggregate

Investigators
Hochschild, Ann
Institutions
Harvard University Medical School
Start date
2008
End date
2013
Objective
Prions are infectious, self-propagating protein aggregates that have been implicated in a number of devastating neurodegenerative diseases known as transmissible spongiform encephalopathies. In humans, themost common TSE, Creutzfeldt-Jakob disease, typically strikes without warning, leading to death within 1 yearof diagnosis for 90% of patients. The TSEs have been attributed to a specific cellular protein (PrP) that has thepotential to convert to a highly structured, sheet-rich aggregated form (referred to as amyloid) that is thought to be the infectious agent. With no therapies that can affect either the outcome or progress of the disease, newexperimental avenues are crucial.

The objective of the proposed research is to mobilize bacterial genetics as a new experimental system for studying prion behavior. Having shown that the E. coli cytoplasm can support the formation of prion-like aggregates, we propose to develop a set of transcription-based genetic assays that can detect conversion of protein domains to the prion state.

Using these assays, we will conduct mutant screens to identify cellular chaperones and other factors that can affect the prion process. Because of the evolutionary conservation of chaperone proteins, such screens may uncover potential new drug targets relevant to mammalian disease.

We will also use bacteria-based genetic assays to screen bacterial genomes as well as the genomes of higher organisms (including mammals) for novel prion proteins. The discovery of bacterial prions could have profound implications for human health, particularly in the context of host-pathogen interactions.

Finally, we envision using bacteria-based genetic assays to screen for small molecules that can hinder conversion to and/or propagation of the prion state. While our primary focus is prion disease, the tools we aim to develop should also be applicable to the large number of non-infectious neurodegenerative diseases that are associated with the formation of amyloid aggregates.

More information
For additional information, including history, sub-projects, results and publications, if available, visit the Project Information web page at the National Institutes of Health Research Portfolio Online Reporting Tool (RePORTER) database.
Funding Source
Office of the Director
Project source
View this project
Project number
1DP1OD003806-01
Categories
Escherichia coli
Microbial Genetics
Viruses and Prions